NCT04311541View on ClinicalTrials.gov

A Study of Dexlansoprazole Modified Release (MR) in Gastroesophageal Reflux Disease (GERD) Participants in the Russian Federation

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

March 15, 2020

Primary Completion Date

June 15, 2021

Study Completion Date

January 31, 2022

Conditions
Gastroesophageal Reflux Disease
Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY